norketobemidone has been researched along with enkephalin, d-penicillamine (2,5)- in 1 studies
| Studies (norketobemidone) | Trials (norketobemidone) | Recent Studies (post-2010) (norketobemidone) | Studies (enkephalin, d-penicillamine (2,5)-) | Trials (enkephalin, d-penicillamine (2,5)-) | Recent Studies (post-2010) (enkephalin, d-penicillamine (2,5)-) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 1,314 | 0 | 73 |
| Protein | Taxonomy | norketobemidone (IC50) | enkephalin, d-penicillamine (2,5)- (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.0016 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christensen, CB; Christrup, LL; Kristensen, K; Nielsen, LC | 1 |
1 other study(ies) available for norketobemidone and enkephalin, d-penicillamine (2,5)-
| Article | Year |
|---|---|
The mu1 and mu2 opioid receptor binding of ketobemidone, norketobemidone and 3-dimethylamino-1,1-diphenylbutene.
Topics: Allylamine; Analgesics, Opioid; Animals; Binding, Competitive; Cattle; Caudate Nucleus; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Humans; Isonipecotic Acids; Meperidine; Parasympatholytics; Phenols; Receptors, Opioid, delta; Receptors, Opioid, mu | 1996 |